ATE404225T1 - Radiofluorierte peptide - Google Patents
Radiofluorierte peptideInfo
- Publication number
- ATE404225T1 ATE404225T1 AT05790076T AT05790076T ATE404225T1 AT E404225 T1 ATE404225 T1 AT E404225T1 AT 05790076 T AT05790076 T AT 05790076T AT 05790076 T AT05790076 T AT 05790076T AT E404225 T1 ATE404225 T1 AT E404225T1
- Authority
- AT
- Austria
- Prior art keywords
- radiofluorinated
- peptides
- processes
- radiopharmaceuticals
- iiia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0420344.4A GB0420344D0 (en) | 2004-09-14 | 2004-09-14 | Diagnostic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE404225T1 true ATE404225T1 (de) | 2008-08-15 |
Family
ID=33186989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05790076T ATE404225T1 (de) | 2004-09-14 | 2005-09-14 | Radiofluorierte peptide |
Country Status (24)
Country | Link |
---|---|
US (2) | US7875701B2 (de) |
EP (1) | EP1791571B1 (de) |
JP (1) | JP4949251B2 (de) |
KR (1) | KR101243016B1 (de) |
CN (1) | CN101151054B (de) |
AT (1) | ATE404225T1 (de) |
AU (1) | AU2005283904B8 (de) |
BR (1) | BRPI0515175A (de) |
CA (1) | CA2578470C (de) |
DE (1) | DE602005008996D1 (de) |
DK (1) | DK1791571T3 (de) |
ES (1) | ES2312018T3 (de) |
GB (1) | GB0420344D0 (de) |
HK (1) | HK1118713A1 (de) |
IL (1) | IL181529A (de) |
MX (1) | MX2007003019A (de) |
NO (1) | NO20071880L (de) |
NZ (1) | NZ553384A (de) |
PL (1) | PL1791571T3 (de) |
PT (1) | PT1791571E (de) |
RU (1) | RU2396272C9 (de) |
SI (1) | SI1791571T1 (de) |
WO (1) | WO2006030291A2 (de) |
ZA (1) | ZA200702700B (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1404371B1 (de) * | 2001-07-10 | 2019-03-13 | GE Healthcare UK Limited | Peptidverbindingen zur zielrichtung von interginrezeptoren |
EP1985624A3 (de) * | 2007-04-23 | 2008-12-24 | Bayer Schering Pharma Aktiengesellschaft | Einschrittiges Verfahren zur Radiofluorierung von biologisch aktiven Verbindungen oder Biomolekülen |
US7666392B2 (en) | 2006-09-15 | 2010-02-23 | Siemens Medical Solutions Usa, Inc. | Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins |
US8247534B2 (en) | 2006-12-13 | 2012-08-21 | Ge Healthcare As | Synthesis of radiofluorinated peptide using microwave activation technology |
WO2008075966A2 (en) * | 2006-12-18 | 2008-06-26 | Ge Healthcare As | Synthesis of a radiofluorinated peptide using photolabile protecting groups |
EP2114464A2 (de) * | 2006-12-28 | 2009-11-11 | GE Healthcare AS | Radiofluorinationsverfahren |
CA2679514A1 (en) * | 2007-03-01 | 2008-09-04 | Bayer Schering Pharma Aktiengesellschaft | 18f fluoro-benzoyl labelled biologically active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy-benzoyl and trimethylammonio-benzoyl precursers |
EP2195037A2 (de) | 2007-09-10 | 2010-06-16 | GE Healthcare UK Limited | Radiofluorinationsverfahren |
WO2009108484A1 (en) | 2008-02-28 | 2009-09-03 | Ge Healthcare Limited | Synthesis of a peg-6 moiety from commercial low-cost chemicals |
GB0905438D0 (en) * | 2009-03-30 | 2009-05-13 | Ge Healthcare Ltd | Radiolabelling reagents and methods |
US8834839B2 (en) * | 2009-04-27 | 2014-09-16 | General Electric Company | Labeled molecular imaging agents, methods of making and methods of use |
GB0910013D0 (en) * | 2009-06-10 | 2009-07-22 | Ge Healthcare Ltd | PET imaging of fibogenesis |
WO2011084763A1 (en) | 2009-12-21 | 2011-07-14 | Ge Healthcare Limited | Borosilicate glassware and silica based qma's in 18f nucleophilic substitution: influence of aluminum, boron and silicon on the reactivity of the 18f ion |
GB201013808D0 (en) * | 2010-08-18 | 2010-09-29 | Ge Healthcare Ltd | Peptide radiotracer compositions |
EP2646060B1 (de) | 2010-12-01 | 2018-05-30 | GE Healthcare Limited | Radiokonjugationsverfahren |
EP2648767B1 (de) * | 2010-12-09 | 2023-03-15 | GE Healthcare Limited | Radiotracer-zusammensetzungen |
US9567372B2 (en) | 2010-12-21 | 2017-02-14 | Ge Healthcare Limited | Use of aniline in the radiostabilization of oxime ligation |
US20130074758A1 (en) | 2011-09-26 | 2013-03-28 | Ocean Power Technologies, Inc. | Anchoring apparatus for wave energy converters |
WO2013048996A1 (en) | 2011-09-30 | 2013-04-04 | Ge Healthcare Limited | Method for the purification of a peptide-based imaging agent precursor |
WO2013048956A2 (en) * | 2011-09-30 | 2013-04-04 | Ge Healthcare Limited | Solid phase extraction separation method |
GB201202420D0 (en) * | 2012-02-13 | 2012-03-28 | Ge Healthcare Ltd | Radiotracer compositions |
GB201221266D0 (en) | 2012-11-27 | 2013-01-09 | Ge Healthcare Ltd | Aldehyde compositions |
GB201314936D0 (en) | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
KR102205845B1 (ko) | 2013-10-28 | 2021-01-22 | 삼성전자주식회사 | 입자에 기반한 모델링 방법 및 장치 |
GB201322456D0 (en) | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
CN106999603B (zh) | 2014-12-04 | 2022-05-27 | 通用电气健康护理有限公司 | 从放射性药物中除去乙醛的方法 |
GB201518918D0 (en) * | 2015-10-26 | 2015-12-09 | Norsk Medisinsk Syklotronsenter As And Uni I Oslo | Method |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1404371B1 (de) * | 2001-07-10 | 2019-03-13 | GE Healthcare UK Limited | Peptidverbindingen zur zielrichtung von interginrezeptoren |
GB0206750D0 (en) * | 2002-03-22 | 2002-05-01 | Amersham Plc | Radiofluorination methods |
GB0305704D0 (en) * | 2003-03-13 | 2003-04-16 | Amersham Plc | Radiofluorination methods |
GB0317815D0 (en) | 2003-07-30 | 2003-09-03 | Amersham Health As | Imaging agents |
-
2004
- 2004-09-14 GB GBGB0420344.4A patent/GB0420344D0/en not_active Ceased
-
2005
- 2005-09-14 ES ES05790076T patent/ES2312018T3/es active Active
- 2005-09-14 MX MX2007003019A patent/MX2007003019A/es active IP Right Grant
- 2005-09-14 CN CN200580030720.1A patent/CN101151054B/zh active Active
- 2005-09-14 JP JP2007530793A patent/JP4949251B2/ja active Active
- 2005-09-14 KR KR1020077005792A patent/KR101243016B1/ko not_active IP Right Cessation
- 2005-09-14 DE DE602005008996T patent/DE602005008996D1/de active Active
- 2005-09-14 AU AU2005283904A patent/AU2005283904B8/en not_active Ceased
- 2005-09-14 PT PT05790076T patent/PT1791571E/pt unknown
- 2005-09-14 EP EP05790076A patent/EP1791571B1/de active Active
- 2005-09-14 AT AT05790076T patent/ATE404225T1/de active
- 2005-09-14 PL PL05790076T patent/PL1791571T3/pl unknown
- 2005-09-14 WO PCT/IB2005/002727 patent/WO2006030291A2/en active IP Right Grant
- 2005-09-14 SI SI200530442T patent/SI1791571T1/sl unknown
- 2005-09-14 RU RU2007108762/04A patent/RU2396272C9/ru not_active IP Right Cessation
- 2005-09-14 US US11/575,163 patent/US7875701B2/en active Active
- 2005-09-14 CA CA2578470A patent/CA2578470C/en not_active Expired - Fee Related
- 2005-09-14 NZ NZ553384A patent/NZ553384A/en not_active IP Right Cessation
- 2005-09-14 BR BRPI0515175-9A patent/BRPI0515175A/pt not_active IP Right Cessation
- 2005-09-14 DK DK05790076T patent/DK1791571T3/da active
-
2007
- 2007-02-22 IL IL181529A patent/IL181529A/en not_active IP Right Cessation
- 2007-03-30 ZA ZA200702700A patent/ZA200702700B/xx unknown
- 2007-04-13 NO NO20071880A patent/NO20071880L/no unknown
-
2008
- 2008-09-18 HK HK08110335.5A patent/HK1118713A1/xx not_active IP Right Cessation
-
2011
- 2011-01-21 US US13/010,814 patent/US8563600B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE404225T1 (de) | Radiofluorierte peptide | |
ES2486675T3 (es) | Análogo de péptido de oxintomodulina | |
EA200802170A1 (ru) | Лиофилизированная композиция терапевтического пептидного антитела | |
ECSP13012436A (es) | ANTICUERPOS PEPTÍDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS | |
SE0301653D0 (sv) | Novel compounds | |
EA201070271A1 (ru) | Пептиды для получения вакцины | |
EA201000844A1 (ru) | Связывающие wise агенты и эпитопы | |
EA201070786A1 (ru) | Бензофуропиримидиноны | |
BRPI0618904A2 (pt) | composto, composição farmacêutica, e, uso do composto | |
DE602006018856D1 (de) | Neue nutrazeutika-zusammensetzungen | |
IS8401A (is) | Fullmanngerð mótefni gegn 4-1BB í mönnum (CD137) | |
CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
NZ612161A (en) | Radiolabled her2 binding peptides | |
UA118167C2 (uk) | Пептид та його застосування | |
ATE298763T1 (de) | Integrinbindende peptidderivate | |
EA200702352A1 (ru) | Новые композиции нутрицевтиков | |
CY1115919T1 (el) | Ενωσεις ενεργοποιησης τελομερασης και μεθοδοι χρησης αυτων | |
DK1838341T3 (da) | Vaccinesammensætning omfattende et fibronectin bindende protein eller et fibronectinbindende peptid | |
EA200801414A1 (ru) | Кальцилитические соединения | |
EA200701172A1 (ru) | 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение | |
CY1110891T1 (el) | Παραγωγα 6-ετεροαρυλπυριδοϊνδολονης, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη αγωγη | |
NO20065806L (no) | Peptid-baserte forbindelser | |
EA200800205A1 (ru) | Кальций-пептидный компонент | |
RS53671B1 (en) | FVIII-Derived Peptides and Their Use in Tolerated Hemophiliacs | |
EA200870565A1 (ru) | 2-алкокси-3,4,5-тригидроксиалкиламидобензазепины, их получение, содержащие их композиции и применение |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1791571 Country of ref document: EP |